Literature DB >> 18443098

The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence.

Daniel Sinsimer1, Gaelle Huet, Claudia Manca, Liana Tsenova, Mi-Sun Koo, Natalia Kurepina, Bavesh Kana, Barun Mathema, Salvatore A E Marras, Barry N Kreiswirth, Christophe Guilhot, Gilla Kaplan.   

Abstract

Mycobacterium tuberculosis possesses a diversity of potential virulence factors including complex branched lipids such as the phenolic glycolipid PGL-tb. PGL-tb expression by the clinical M. tuberculosis isolate HN878 has been associated with a less efficient Th1 response and increased virulence in mice and rabbits. It has been suggested that the W-Beijing family is the only group of M. tuberculosis strains with an intact pks1-15 gene, required for the synthesis of PGL-tb and capable of producing PGL-tb. We have found that some strains with an intact pks1-15 do not produce PGL-tb while others may produce a variant of PGL-tb. We examined the early host cytokine response to infection with these strains in vitro to better understand the effect of PGL-tb synthesis on immune responses. In addition, we generated a PGL-tb-producing H37Rv in order to determine the effect of PGL-tb production on the host immune response during infection by a strain normally devoid of PGL-tb synthesis. We observed that PGL-tb production by clinical M. tuberculosis isolates affected cytokine production differently depending on the background of the strain. Importantly, while ectopic PGL-tb production by H37Rv suppressed the induction of several pro- and anti-inflammatory cytokines in vitro in human monocytes, it did not lead to increased virulence in infected mice and rabbits. Collectively, our data indicate that, while PGL-tb may play a role in the immunogenicity and/or virulence of M. tuberculosis, it probably acts in concert with other bacterial factors which seem to be dependent on the background of the strain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443098      PMCID: PMC2446685          DOI: 10.1128/IAI.01663-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Comparison of DNA fragment patterns between the phenolic glycolipid-Tb producers and non-producers of Mycobacterium tuberculosis.

Authors:  T Y Lee; S N Cho; K H Yoon; J S Shin; J D Kim
Journal:  Yonsei Med J       Date:  1991-09       Impact factor: 2.759

3.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

4.  The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated.

Authors:  Michael B Reed; Sebastien Gagneux; Kathryn Deriemer; Peter M Small; Clifton E Barry
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

5.  The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Marisa Harton; Gopinath Palanisamy; Jolynn Troudt; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

6.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

7.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.

Authors:  A M Cooper; A D Roberts; E R Rhoades; J E Callahan; D M Getzy; I M Orme
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

8.  Production of monoclonal antibody to a phenolic glycolipid of Mycobacterium tuberculosis and its use in detection of the antigen in clinical isolates.

Authors:  S N Cho; J S Shin; M Daffe; Y Chong; S K Kim; J D Kim
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; J Sypek; S Wolf; B R Bloom
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

10.  Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes.

Authors:  A Molloy; P A Meyn; K D Smith; G Kaplan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  55 in total

Review 1.  Comparative genomics of mycobacteria: some answers, yet more new questions.

Authors:  Marcel A Behr
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

2.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

3.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

4.  Comparative lipidomics of drug sensitive and resistant Mycobacterium tuberculosis reveals altered lipid imprints.

Authors:  Rahul Pal; Saif Hameed; Parveen Kumar; Sarman Singh; Zeeshan Fatima
Journal:  3 Biotech       Date:  2017-09-16       Impact factor: 2.406

5.  Biosynthesis of cell envelope-associated phenolic glycolipids in Mycobacterium marinum.

Authors:  Olivia Vergnolle; Sivagami Sundaram Chavadi; Uthamaphani R Edupuganti; Poornima Mohandas; Catherine Chan; Julie Zeng; Mykhailo Kopylov; Nicholas G Angelo; J David Warren; Clifford E Soll; Luis E N Quadri
Journal:  J Bacteriol       Date:  2015-01-05       Impact factor: 3.490

6.  The mycobacterial acyltransferase PapA5 is required for biosynthesis of cell wall-associated phenolic glycolipids.

Authors:  Sivagami Sundaram Chavadi; Kenolisa C Onwueme; Uthamaphani R Edupuganti; Jeff Jerome; Delphi Chatterjee; Clifford E Soll; Luis E N Quadri
Journal:  Microbiology (Reading)       Date:  2012-02-23       Impact factor: 2.777

Review 7.  Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches.

Authors:  Stefan Niemann; Philip Supply
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-04       Impact factor: 6.915

Review 8.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

9.  Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains.

Authors:  Christopher D Intemann; Thorsten Thye; Stefan Niemann; Edmund N L Browne; Margaret Amanua Chinbuah; Anthony Enimil; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Susanne Helm; Sabine Rüsch-Gerdes; Rolf D Horstmann; Christian G Meyer
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

10.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.